☆ 4.5 Editorial Material

Clinical development plan for regenerative therapy in heart failure

EUROPEAN JOURNAL OF HEART FAILURE (2016)

期刊

EUROPEAN JOURNAL OF HEART FAILURE

卷 18, 期 2, 页码 142-144

出版社

WILEY

DOI: 10.1002/ejhf.479

关键词

-

类别

Cardiac & Cardiovascular Systems

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy

Keitaro Domae, Shigeru Miyagawa, Yasushi Yoshikawa, Satsuki Fukushima, Hiroki Hata, Shunsuke Saito, Satoshi Kainuma, Noriyuki Kashiyama, Hiroko Iseoka, Emiko Ito, Akima Harada, Maki Takeda, Yasushi Sakata, Koichi Toda, Kyongsun Pak, Tomomi Yamada, Yoshiki Sawa

Summary: This clinical study showed that autologous skeletal cell-patch implantation may benefit functional recovery and clinical outcomes in patients with nonischemic dilated cardiomyopathy, along with safety and feasibility.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Insights into therapeutic products, preclinical research models, and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC Working Group on Cardiovascular Regenerative and Reparative Medicine

Lilian Grigorian-Shamagian, Ricardo Sanz-Ruiz, Andreu Climent, Lina Badimon, Lucio Barile, Roberto Bolli, Steven Chamuleau, Diederick E. Grobbee, Stefan Janssens, Jens Kastrup, Leyla Kragten-Tabatabaie, Rosalinda Madonna, Anthony Mathur, Philippe Menasche, Giulio Pompilio, Felipe Prosper, Emily Sena, Nicola Smart, Wolfgram-Hubertus Zimmermann, Francisco Fernandez-Aviles

Summary: The text highlights the potential and challenges of regenerative and reparative medicine in the treatment of cardiovascular diseases, particularly heart failure. It discusses the discrepancies between preclinical studies and clinical trials, as well as the barriers to clinical translation. It also calls for a better preparation for stem cell and gene therapy products in the clinical setting.

CARDIOVASCULAR RESEARCH (2021)

添加到收藏夹

Review Polymer Science

Injectable Hydrogels for Improving Cardiac Cell Therapy-In Vivo Evidence and Translational Challenges

Cecilie Hoeeg, Alireza Dolatshahi-Pirouz, Bjarke Follin

Summary: Cell therapy has the potential to regenerate cardiac tissue and treat various cardiac diseases. Injectable hydrogels have been investigated for their potential to improve cell graft retention and enhance the effects of cardiac cell therapy.

GELS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease

Kartik Andi, Omar Abozied, William R. Miranda, Jason H. Anderson, Heidi M. Connolly, C. Charles Jain, Luke J. Burchill, Alexander C. Egbe

Summary: This retrospective cohort study compared the clinical benefits of angiotensin receptor-neprilysin inhibitor (ARNI) with angiotensin converting enzyme inhibitor or angiotensin-II receptor blocker (ACEI/ARB) in adults with congenital heart disease (CHD). The results showed that ARNI was associated with improved biventricular systolic function, functional status, and neurohormonal activation. These findings provide a foundation for further research on the prognostic benefits of ARNI in this population.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Gene therapy during ex situ heart perfusion: a new frontier in cardiac regenerative medicine?

Mats T. Vervoorn, Jantijn J. G. J. Amelink, Elisa M. Ballan, Pieter A. Doevendans, Joost P. G. Sluijter, Mudit Mishra, Gerard J. J. Boink, Dawn E. Bowles, Niels P. van der Kaaij

Summary: Machine perfusion for ex situ organ preservation improves organ transplantation outcomes and potentially allows for selective immunomodulation, ischemia-reperfusion injury tolerance, and correction of genetic defects. Gene modifying therapies during ex situ heart perfusion offer promising treatment options for heart diseases caused by pathogenic mutations.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Recent Progress in the Development and Clinical Application of New Drugs for Transthyretin Cardiac Amyloidosis

Juan Zhou, Yanfang Li, Jing Geng, Hong Zhou, Lian Liu, Xiaochun Peng

Summary: Transthyretin cardiac amyloidosis is a rare disease with an insidious onset and nonspecific clinical manifestations. The extent of heart involvement determines the survival time of patients, and conventional treatments are not effective. Liver transplantation and combined hepato-heart transplantation have been effective means of treatment, but have limitations. The development of new drugs in recent years has brought hope to patients.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Development of direct cardiac reprogramming for clinical applications

Yu Yamada, Taketaro Sadahiro, Masaki Ieda

Summary: The incidence of cardiovascular diseases is increasing globally, and cardiac regenerative therapy shows great potential as a new treatment strategy, particularly for ischemic heart disease. One promising approach is direct cardiac reprogramming, where specific factors are used to convert cardiac fibroblasts into induced cardiomyocyte-like cells. In vivo reprogramming has shown promising results in improving cardiac function and reducing scarring after a myocardial infarction. This review summarizes recent advances in in vivo cardiac reprogramming and discusses its future clinical applications and challenges in direct human reprogramming.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2023)

添加到收藏夹

Review Medicine, General & Internal

Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?

Paolo Severino, Andrea D'Amato, Silvia Prosperi, Alessandra Dei Cas, Anna Vittoria Mattioli, Antonio Cevese, Giuseppina Novo, Maria Prat, Roberto Pedrinelli, Riccardo Raddino, Sabina Gallina, Federico Schena, Corrado Poggesi, Pasquale Pagliaro, Massimo Mancone, Francesco Fedele

Summary: Heart failure is a multisystemic disease that requires evaluation and treatment based on key parameters such as left ventricular ejection fraction (LVEF). The definition and therapy of HF need to be revised to move away from the old simplistic perspective.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Editorial Material Genetics & Heredity

Opportunities and challenges for artificial intelligence in clinical cardiovascular genetics

Chayakrit Krittanawong, Kipp W. Johnson, Benjamin S. Glicksberg

Summary: The combination of emerging genomic and artificial intelligence techniques may lead to a deeper understanding of heterogeneity and biological complexities in cardiovascular diseases, advancing prognostic guidance and personalized therapies. Discussions on the current state, applications, limitations, and future directions of AI in cardiovascular genetics are presented.

TRENDS IN GENETICS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Exosomes isolated from human cardiosphere-derived cells attenuate pressure overload-induced right ventricular dysfunction

Gregory J. Bittle, David Morales, Nicholas Pietris, Nathaniel Parchment, Dawn Parsell, Kiel Peck, Kristopher B. Deatrick, Luis Rodriguez-Borlado, Rachel R. Smith, Linda Marban, Sunjay Kaushal

Summary: In a juvenile porcine model, human CDC-derived exosome administration showed significant preservation of RV systolic function in the setting of acute pressure overload, leading to improved cardiac function and reduced cardiomyocyte hypertrophy. These acellular preparations may be superior to whole cells and represent a novel therapeutic approach to clinical myocardial injury.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system

Jurgen Kuschyk, Peter Falk, Thomas Demming, Oliver Marx, Deborah Morley, Ishu Rao, Daniel Burkhoff

Summary: Cardiac contractility modulation therapy improved functional status, quality of life, and LVEF, while reducing heart failure hospitalization rates. Survival at 1 and 3 years was significantly better than predicted by the MAGGIC risk score.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation

Rachael S. Watson-Levings, Glyn D. Palmer, Padraic P. Levings, E. Anthony Dacanay, Christopher H. Evans, Steven C. Ghivizzani

Summary: Gene-based treatment approaches are being investigated in orthopaedics for various pathologic conditions of the skeletal connective tissues and structures. The delivery of coding sequences for biologic agents to cells shows potential in enhancing tissue repair and inhibiting degenerative diseases.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Treatment of Cardiac Fibrosis with Extracellular Vesicles: What Is Missing for Clinical Translation?

Sebastian Neuber, Miriam R. Ermer, Maximilian Y. Emmert, Timo Z. Nazari-Shafti

Summary: Heart failure is a major cause of morbidity and mortality, affecting over 60 million people worldwide. Cardiac fibrosis, characterized by excessive accumulation of extracellular matrix components, plays a key role in heart failure pathogenesis. While beneficial in the short term, persistent cardiac fibrosis leads to pathological remodeling and dysfunction of the heart. Standard therapies targeting cardiac fibrosis are currently lacking, but extracellular vesicles (EVs) derived from stem and progenitor cells show promise as a potential treatment. However, standardized methods for EV production, isolation, characterization, and storage, along with clinical evidence of their safety and efficacy, are still needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Cell & Tissue Engineering

Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome

D. Kent Arrell, Ruben J. Crespo-Diaz, Satsuki Yamada, Ryounghoon Jeon, Armin Garmany, Sungjo Park, Jeffrey P. Adolf, Christopher Livia, Matthew L. Hillestad, Jozef Bartunek, Atta Behfar, Andre Terzic

Summary: Stem cell paracrine activity, specifically secreted proteins by cardiopoietic cells, play a key role in cardiac repair. Through systems analytics and RNA sequencing, miR-146 was identified as a regulator upstream of the decoded secretome. The therapeutic impact of cardiopoietic cell therapy on infarcted hearts is influenced by the inherent vasculogenic properties and smooth muscle differentiation of the secreted proteins.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Cardiac fibrosis: emerging agents in preclinical and clinical development

Roberto Spoladore, Giulio Falasconi, Giorgio Fiore, Silvana Di Maio, Alberto Preda, Massimo Slavich, Alberto Margonato, Gabriele Fragasso

Summary: Myocardial fibrosis is a dynamic process with potential therapeutic targets such as TGF-beta, cTGF, and Gal-3. Clinical practice involves drugs with anti-fibrotic properties, while preclinical studies show promise for new drugs in targeting cardiac fibrosis and improving left ventricular function. However, there is a lack of clinical trials and engineered molecules for specific targets in this field.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

添加到收藏夹

Article Engineering, Biomedical

Correction of High Afterload Improves Low Cardiac Output in Patients Supported on Left Ventricular Assist Device Therapy

Andrew N. Rosenbaum, Alfredo L. Clavell, John M. Stulak, Atta Behfar

Summary: There is a lack of data on the invasive assessment of afterload and its impact on cardiac output in patients on LVAD therapy. Despite no direct association between mean aortic pressure (MAP) and cardiac index (CI), varying MAP levels led to different cardiac output responses to speed increments. Patients with elevated MAP were found to benefit from nitrate therapy, demonstrating improved biventricular filling pressures and increased cardiac index. High afterload in LVAD patients is common, but can be improved with nitrates, highlighting the importance of further research on the effects of high afterload and chronic vasodilator therapy in this patient population.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Engineering, Biomedical

Inadequate left ventricular unloading during ramp is associated with hospitalization or death during left ventricular assist device support

Andrew N. Rosenbaum, John M. Stulak, Alfredo L. Clavell, Atta Behfar

Summary: This study evaluated the prognostic significance of hemodynamic indices in LVAD patients and found that LVEDP is a central prognostic marker in this population.

ARTIFICIAL ORGANS (2021)

添加到收藏夹

Article Engineering, Biomedical

Outcomes of Ambulatory Heart Failure Patients Managed With an Intra-aortic Balloon Pump Before Left Ventricular Assist Device Implantation

Bradley Ternus, Atta Behfar, John Schirger, Gregory Barsness, Mackram Eleid, Parag Patel, John Stulak, Jacob Jentzer

Summary: This study aimed to evaluate the clinical outcomes of hemodynamic optimization using IABP in high-risk heart failure patients before LVAD implantation. The results showed that patients treated with IABP before LVAD implantation had better reductions in pulmonary artery pressures without an increase in postoperative complications.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Systolic-to-diastolic myocardial volume ratio as a novel imaging marker of cardiomyopathy

Alexander J. Ryu, Vinayak Kumar, Barry A. Borlaug, Armando Manduca, Chaitanya K. Rao, Raymond J. Gibbons, Samuel J. Asirvatham, Bernard J. Gersh, Krishnaswamy Chandrasekaran, Philip A. Araoz, Jae K. Oh, Alexander C. Egbe, Atta Behfar, Nandan S. Anavekar

Summary: The study investigated the ratio of myocardial volume in systole to myocardial volume in diastole (MVs/MVd) to differentiate between normal hearts and various cardiomyopathies with normal ejection fractions. Results showed significant differences in MVs/MVd ratio between pathological subgroups and normal subjects, suggesting its potential as a novel and easily-captured metric for assessing ventricular function. The study concluded that MVs/MVd ratio can effectively distinguish normal ventricular function from different cardiomyopathies, indicating its clinical utility in assessing heart disease.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation

Andrew N. Rosenbaum, Bradley W. Ternus, Siddharth Pahwa, John M. Stulak, Alfredo L. Clavell, Sarah D. Schettle, Atta Behfar, Jacob C. Jentzer

Summary: In patients undergoing left ventricular assist device implantation, right ventricular stroke work index, right heart catheterization, cardiopulmonary bypass time, and ultrafiltration are strongly associated with incident INT-LD and decreased 1-year survival. Optimization of these factors may reduce the risk of liver dysfunction but further validation is needed.

ANNALS OF THORACIC SURGERY (2021)

添加到收藏夹

Article Engineering, Biomedical

Percutaneous Axillary Intra-aortic Balloon Pump Insertion Technique as Bridge to Advanced Heart Failure Therapy

Andrew N. Rosenbaum, C. Charles Jain, Ilya Y. Shadrin, Stephanie C. El Hajj, Abdallah El Sabbagh, Atta Behfar

Summary: In patients with advanced heart failure, the use of percutaneous axillary intra-aortic balloon pump for temporary mechanical circulator support is feasible and associated with an acceptable complication rate as a bridge to definitive therapy, facilitating ambulation and improving outcomes.

ASAIO JOURNAL (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Brachyury engineers cardiac repair competent stem cells

Mark Li, Satsuki Yamada, Ao Shi, Raman Deep Singh, Tyler J. Rolland, Ryounghoon Jeon, Natalia Lopez, Lukas Shelerud, Andre Terzic, Atta Behfar

Summary: By introducing early cardiogenic genes, engineered cardiac repair competent stem cells with antioxidant, vasculogenic, and immunomodulatory traits have been successfully developed. These stem cells have important application value in treating heart diseases such as ischemic heart failure.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients

Richard C. Daly, Andrew N. Rosenbaum, Joseph A. Dearani, Alfredo L. Clavell, Naveen L. Pereira, Barry A. Boilson, Robert P. Frantz, Atta Behfar, Shannon M. Dunlay, Richard J. Rodeheffer, John A. Schirger, Timucin Taner, Manish J. Gandhi, Julie K. Heimbach, Charles B. Rosen, Brooks S. Edwards, Sudhir S. Kushwaha

Summary: This study demonstrates the successful transplantation using a heart-after-liver transplantation protocol, which provides profound immunologic protection and prevents adverse immunological outcomes in highly sensitized patients requiring combined heart-liver transplantation. The results show near-elimination of donor specific antibodies and minimal rejection episodes, leading to favorable long-term patient and graft outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Review Cell & Tissue Engineering

Regenerative medicine clinical readiness

Satsuki Yamada, Atta Behfar, Andre Terzic

Summary: Regenerative medicine aims to provide more care options for patients in need through technological innovation, helping them to get cured. Through responsible and regulated translation, regenerative medical technology is applied to the treatment of serious diseases and disabilities. By advancing the design, manufacture, and effectiveness of regenerative solutions, the goal is to democratize health benefits for all.

REGENERATIVE MEDICINE (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Impact of Repeat Dosing and Mesh Exposure Chronicity on Exosome-Induced Vaginal Tissue Regeneration in a Porcine Mesh Exposure Model

Cassandra K. Kisby, Ilya Y. Shadrin, Lillian T. Peng, Paul G. Stalboerger, Emanuel C. Trabuco, Atta Behfar, John A. Occhino

Summary: The study compared vaginal wound healing in a porcine mesh exposure model after exosome injection, looking at single vs. multiple dose regimens and acute vs. subacute exposure. Results showed that redosing with exosomes led to significantly higher epithelial proliferation and regenerated capillary density, with a trend towards thicker epithelium. Subacute exposure demonstrated similar regeneration to acute exposure despite a delayed injection timeline.

FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Listening for Thrombosis

Michael S. Sabbah, Andrew N. Rosenbaum, Atta Behfar

MAYO CLINIC PROCEEDINGS (2021)

添加到收藏夹

Editorial Material Cell & Tissue Engineering

From tissue to human regeneration: the development of a comprehensive regenerative care clinic for people with diabetes

Ian G. Hargraves, Atta Behfar, Vinaya Simha, Chenoa Donoghue, Amy Seegmiller Renner, Victor M. Montori, Juan P. Brito

REGENERATIVE MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

An under-recognized phenomenon: Myocardial volume change during the cardiac cycle

Vinayak Kumar, Armando Manduca, Chaitanya Rao, Alexander J. Ryu, Raymond J. Gibbons, Bernard J. Gersh, Krishnaswamy Chandrasekaran, Samuel J. Asirvatham, Philip A. Araoz, Jae K. Oh, Alexander C. Egbe, Atta Behfar, Barry A. Borlaug, Nandan S. Anavekar

Summary: This study analyzed myocardial strain values from healthy patients and found that myocardial volume decreases during systole. Sensitivity analysis showed that strain values are the primary determinant of myocardial volume changes.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome

D. Kent Arrell, Ruben J. Crespo-Diaz, Satsuki Yamada, Ryounghoon Jeon, Armin Garmany, Sungjo Park, Jeffrey P. Adolf, Christopher Livia, Matthew L. Hillestad, Jozef Bartunek, Atta Behfar, Andre Terzic

Summary: Stem cell paracrine activity, specifically secreted proteins by cardiopoietic cells, play a key role in cardiac repair. Through systems analytics and RNA sequencing, miR-146 was identified as a regulator upstream of the decoded secretome. The therapeutic impact of cardiopoietic cell therapy on infarcted hearts is influenced by the inherent vasculogenic properties and smooth muscle differentiation of the secreted proteins.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo

Ao Shi, Jialun Li, Xinyuan Qiu, Michael Sabbah, Soulmaz Boroumand, Tony Chieh-Ting Huang, Chunfeng Zhao, Andre Terzic, Atta Behfar, Steven L. Moran

Summary: This study developed a clinical-grade platelet exosome product (PEP) combined with injectable surgical fibrin sealant (TISSEEL) to promote chronic wound healing and skin regeneration. The PEP showed promising results in stimulating cellular activities and enhancing wound healing capacity.

THERANOSTICS (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.